Whitehawk Therapeutics DEF 14A: Executive Pay & Governance
Ticker: WHWK · Form: DEF 14A · Filed: Apr 28, 2025 · CIK: 1422142
| Field | Detail |
|---|---|
| Company | Whitehawk Therapeutics, INC. (WHWK) |
| Form Type | DEF 14A |
| Filed Date | Apr 28, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, executive-compensation, corporate-governance
TL;DR
Whitehawk Therapeutics (fka Aadi) DEF 14A out: exec comp details for 2024, board info.
AI Summary
Whitehawk Therapeutics, Inc. (formerly Aadi Bioscience, Inc.) filed its DEF 14A on April 28, 2025, detailing executive compensation and corporate governance matters for the fiscal year ending December 31, 2024. The filing includes information on named executive officers such as Lennon, Delaney, Giacobello, and Desai, and their compensation packages. It also covers the company's board of directors and various committee memberships.
Why It Matters
This filing provides transparency into how Whitehawk Therapeutics compensates its top executives and outlines the structure of its board, which can influence strategic decisions and shareholder value.
Risk Assessment
Risk Level: medium — DEF 14A filings are routine disclosures, but they can reveal information about executive compensation and corporate governance that may impact investor confidence and stock performance.
Key Numbers
- 2024 — Fiscal Year End (Reporting period for compensation and governance details.)
- 20250428 — Filing Date (Date the DEF 14A was filed with the SEC.)
Key Players & Entities
- Whitehawk Therapeutics, Inc. (company) — Filer
- Aadi Bioscience, Inc. (company) — Former company name
- Lennon (person) — Named Executive Officer
- Delaney (person) — Named Executive Officer
- Giacobello (person) — Named Executive Officer
- Desai (person) — Named Executive Officer
FAQ
What is the primary purpose of a DEF 14A filing?
A DEF 14A filing, also known as a Definitive Proxy Statement, is filed by companies to solicit proxies from shareholders for an upcoming annual or special meeting, and it contains detailed information about executive compensation, board of directors, and corporate governance.
Who are the key individuals mentioned in relation to executive compensation for Whitehawk Therapeutics?
The filing mentions individuals such as Lennon, Delaney, Giacobello, and Desai in the context of executive compensation for the fiscal year 2024.
When was Whitehawk Therapeutics formerly known as?
Whitehawk Therapeutics, Inc. was formerly known as Aadi Bioscience, Inc., with a name change date of 20210826.
What is the fiscal year end for Whitehawk Therapeutics?
The fiscal year end for Whitehawk Therapeutics is December 31st (1231).
What is the business address of Whitehawk Therapeutics?
The business address for Whitehawk Therapeutics is 2 Headquarters Plaza, East Building, 11th Floor, Morristown, NJ 07960.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 28, 2025 by Lennon regarding Whitehawk Therapeutics, Inc. (WHWK).